Chapter 69.48 RCW
DRUG TAKE-BACK PROGRAM
Sections
HTMLPDF | 69.48.010 | Findings. |
HTMLPDF | 69.48.020 | Definitions. |
HTMLPDF | 69.48.030 | Requirement to participate in a drug take-back program. |
HTMLPDF | 69.48.040 | Identification of covered manufacturers. |
HTMLPDF | 69.48.050 | Drug take-back program approval—Program modifications. |
HTMLPDF | 69.48.060 | Collection system. |
HTMLPDF | 69.48.070 | Drug take-back program promotion. |
HTMLPDF | 69.48.080 | Disposal and handling of covered drugs. |
HTMLPDF | 69.48.090 | Program funding. |
HTMLPDF | 69.48.100 | Annual program report. |
HTMLPDF | 69.48.110 | Enforcement and penalties. |
HTMLPDF | 69.48.120 | Department to set program fees. |
HTMLPDF | 69.48.130 | Secure drug take-back program account. |
HTMLPDF | 69.48.140 | Antitrust immunity. |
HTMLPDF | 69.48.150 | Federal law, effect on this chapter. |
HTMLPDF | 69.48.160 | Local ordinances—Grandfathering—Preemption. |
HTMLPDF | 69.48.170 | Public disclosure. |
HTMLPDF | 69.48.180 | Rule making. |
HTMLPDF | 69.48.190 | Report to legislature. |
HTMLPDF | 69.48.200 | Survey. |
NOTES:
Reviser's note—Sunset Act application: The drug take-back program is subject to review, termination, and possible extension under chapter 43.131 RCW, the Sunset Act. See RCW 43.131.423. RCW 69.48.010 through 69.48.200 are scheduled for future repeal under RCW 43.131.424.